Evidence map›Paper›PMID 37162510›Full record

ReviewDermatologie (Heidelberg, Germany)2023

[Hand eczema or psoriasis: update on the FB 323 study occupational dermatology cohort].

Philipp Bentz, Kilian Eyerich, Christoph Skudlik, Claudia Schröder-Kraft, Harald Löffler, Claudia Pföhler, Reinhardt Leitz, Karisa Thölken, Elke Weisshaar

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Dermatologie (Heidelberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Chronic Hand Eczema.American journal of clinical dermatology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Philipp BentzSektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Voßstr. 2, 69115, Heidelberg, Deutschland. philipp.bentz@med.uni-heidelberg.de.
Kilian EyerichKlinik für Dermatologie und Venerologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.
Christoph SkudlikInstitut für Interdisziplinäre Dermatologische Prävention und Rehabilitation (iDerm), Universität Osnabrück, Osnabrück, Deutschland.
Claudia Schröder-KraftInstitut für interdisziplinäre dermatologische Prävention und Rehabilitation (iDerm), BG Klinikum Hamburg, Hamburg, Deutschland.
Harald LöfflerKlinik für Dermatologie, Allergologie und Phlebologie, SLK-Kliniken Heilbronn, Heilbronn, Deutschland.
Claudia PföhlerKlinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum des Saarlandes, Homburg, Deutschland.
Reinhardt LeitzHautarztpraxis Dr. Leitz und Kollegen, Stuttgart, Deutschland.
Karisa ThölkenKlinik für Dermatologie und Allergologie, Universitätsklinikum Augsburg, Augsburg, Deutschland.
Elke WeisshaarSektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Voßstr. 2, 69115, Heidelberg, Deutschland.
BG Klinikum Hamburg · DEHeidelberg University · DEOsnabrück University · DESLK-Kliniken Heilbronn · DEUniversitätsklinikum des Saarlandes · DEUniversity Hospital Augsburg · DEUniversity Hospital Heidelberg · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In daily dermatological practice, the distinction between eczema and psoriasis in dermatoses of the hands can be difficult. However, a clear diagnosis is necessary to initiate optimal therapy and management. In recent years, the so-called molecular classifier has been developed for optimized differentiation of eczema and psoriasis. An occupational dermatological cohort has been established at Heidelberg University Hospital since 2020. It is funded by the German Statutory Accident Insurance. The aim is to follow-up patients over 3 years where this new diagnostic method is used and to compare the results with a retrospective occupational dermatological cohort. Recruitment ended in December 2022. The current analysis reports participants' occupational activity, insurance status, disease progression, and number of sick days. A total of 287 patients were included; mean age was 50.4 years and 63.5% (n = 181) were undergoing treatment at the expense of the liable statutory accident insurance at the start of the study. About 50% of the patients worked in health professions, metal industry, or construction. The average duration of occupational dermatosis was 6.5 years. In 38.9% of the patients, the clinical diagnosis had been classified as unclear by the treating dermatologist. By using the molecular classifier, the diagnosis could be clarified in 98% of the cases (eczema vs. psoriasis). The first analyses demonstrate that the molecular classifier contributes to improving therapy by optimizing the diagnosis.

Indexed as

Dermatitis, OccupationalDermatologyEczemaHand DermatosesPsoriasisHumansMiddle AgedRetrospective StudiesCohort studyDifferential diagnosisMolecular classifierMolecular diagnosticsOccupational dermatology

Identifiers

PMID37162510
OpenAlexW4376121229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.